SCHEMBL1002486

SCHEMBL1002486

CN(CCCC[Si](C)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)CCCS(=O)(=O)O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003619 0.81
SCHEMBL10024564 0.76
SCHEMBL10024565 0.75
SCHEMBL1244416 0.72 LTA4H (0.32) LTA4H
SCHEMBL19353684 0.71 LTA4H (0.35) LTA4H
SCHEMBL1004580 0.70 ALDH1A1 (0.33)
SCHEMBL1245106 0.69 LTA4H (0.32) LTA4H
SCHEMBL2490043 0.68 LTA4H (0.36) LTA4H
SCHEMBL23016833 0.68 APP (0.38) LTA4H
SCHEMBL16063018 0.68 APP (0.38) LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2237670-B1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MAT INC (US) 2014-10-22 EP disclosed
EP-2237673-B1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MAT INC (US) 2014-09-10 EP disclosed
US-8470894-B2 Hydrolysis resistant organomodified trisiloxane ionic surfactants MOMENTIVE PERFORMANCE MATERIALS (US) 2013-06-25 US disclosed
US-8263669-B2 Hydrolysis resistant organomodified trisiloxane ionic surfactants MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2012-09-11 US disclosed
US-20120142535-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. 2012-06-07 US disclosed
US-20110028569-A1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. 2011-02-03 US disclosed
US-20110021644-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. 2011-01-27 US disclosed
EP-2237670-A2 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS Momentive Performance Materials Inc. (US) 2010-10-13 EP disclosed
EP-2237673-A2 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS Momentive Performance Materials Inc. (US) 2010-10-13 EP disclosed
US-20090173912-A1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-07-09 US disclosed
US-20090176893-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-07-09 US disclosed
WO-2009085300-A2 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-07-09 WO disclosed
WO-2009085297-A2 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028569-A1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS CHRM1, CHRM2, CD209 LTA4H 1634/4885
US-20090176893-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS CHRM2, CHRM1, MSR1 LTA4H 1176/4885
US-20120142535-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS CHRM2, CHRM1, MSR1 LTA4H 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.